The imaging features of 42 histopathologically confirmed cases of Gastrointestinal Stromal Tumors (GIST) were analyzed, to observe the pattern of metastasis. At presentation 22 of 42 patients (52.3%) showed metastasis. During follow-up, three more cases developed metastasis, within one year of resection. Mesentery, omentum, and liver were the most frequent sites for metastasis. Other sites that were rarely reported to be involved were increasingly recognized to show metastasis due to longer survival. The metastasis often showed attenuation and enhancement characteristics, similar to primary GIST, and frequently showed necrosis, hemorrhage, and calcification.
INTRODUCTION
Gastrointestinal stromal tumors (GIST) are a group of smooth muscle mesenchymal tumors of variable malignancy. They account for 0.1 to 3% of all gastrointestinal neoplasms and 5 − 7% of sarcomas. [1] GISTs are defined as spindle cell, epitheloid, or occasionally pleomorphic mesenchymal tumors of the gastrointestinal tract, which express the KIT protein (CD117, stem cell factor receptor) detected on immunohistochemistry. They are thought to arise from interstitial cells of Cajal -a pleuripotent mesenchymal stem cell that acts as a pacemaker for controlling motility. The tumor can arise from any part of the gastrointestinal tract, mesentery, and omentum. [2] Sometimes, the origin cannot be established, because of an extensive peritoneal spread. These tumors occur in middle-aged and older patients, with no sex predilection. The symptoms are minimal in the early stage and go unnoticed, and by the time of presentation, the tumor is often large and spreads to other organs. One-third of the GISTs are malignant and their recurrence rate is about 90%. [3] A computed tomography (CT) scan is the most valuable investigation for the initial diagnosis and staging. The management of GISTs has been revolutionized after the advent of Imatinib. Effective management requires regular imaging assessment. Positron emission tomography (PET)-CT will become the Gold Standard for assessment of response, by virtue of its unique diagnostic functional characteristics when combined with CT, which shows a picture of better quality. This study is aimed at analyzing the radiological pattern of metastasis in cases of gastrointestinal stromal tumors and to define the role of a CT scan in diagnosis and staging.
MATERIALS AND METHODS
A total of 42 histologically confirmed cases were included and the imaging findings were analyzed. Ultrasound and CT scans were done in all cases in our institute. The age of the patients ranged from 24 years to 82 years. Majority were in the 40 − 60 year age group (n = 21) with a male : female ratio of 2 : 1. Table 1 shows the sites of metastasis in the 42 cases that formed the study group. The primary tumor was localized to the stomach (n = 11), small bowel (n = 18), rectum (n = 6), esophagus (n = 3), mesentery (n = 1), and retroperitoneum (n = 1). There were two cases with extensive peritoneal deposits and the origin could not be established. At presentation, 22 of the 42 (52.3%) patients had metastasis. Mesentery, omentum, and liver were the most frequent sites of metastasis. Three patients did not show metastasis at presentation, but developed metastasis after resection of the primary tumor. Nilsson et al., reported that at least 50% of the GISTs have metastasis at presentation. [4] In a recent report from India, metastasis from GIST has been most commonly reported in the liver and peritoneal cavity. Metastasis to the lymph nodes, lungs, bone, subcutaneous tissue, and brain are rare. [5] According to Katz SC et al., liver metastasis occurs in 65% and metastasis in the peritoneum in 21 − 45% the cases. [6] In our study, 52.3% had metastasis at their first presentation and liver, mesentery, and omentum were the most affected sites.
RESULTS

DISCUSSION
Liver metastasis
In our study, 12 (28%) cases showed liver metastasis. A heterogeneous enhancing mass was seen in five cases and a hypodense mass in two cases. In these two cases, one had dense homogenous enhancement and the other had minimal peripheral enhancement. Four cases had predominant cystic attenuation, with thin, solid, enhancing soft tissue at the periphery showing neovascularity. A small amount of bleeding was seen in one of the liver metastasis [ Figure 1 ]. The liver is the most common site of metastasis, both at the time of presentation and during relapse. It is seen in 49 − 65% of the cases. [6, 7] Different authors have described various appearances of liver metastasis. However, lesions appear similar to the primary mass in many cases. They are usually multiple, involve both lobes, and appear heterogeneous with peripheral enhancement. Low attenuation at the center may be due to necrosis and the enhancing peripheral portion represents the solid mass. Usually the tumor enhances in the late arterial or portal venous phase as it spreads through the portal vein. Neovascularity is also shown in the solid part of metastasis [ Figure 2 ]. As some lesions enhance in the arterial phase, triple phase CT of the liver is mandatory. Sometimes, liver lesions may show hypoattenuation on a plain scan and enhance homogenously on a contrast scan. Cystic mass with fluid−fluid level and at times multilocular appearance may be seen. The variegated appearance is due to tumor necrosis, protein material, bleeding, and calcification [ Figure 1 ]. With treatment there is rapid transition from a heterogeneously hypoattenuating pattern, with resolution of the enhancing tumor nodule and decrease in tumor vessel. The density of the hepatic metastasis decreases to 20 − 25 HU, appearing cystic [ Figure 3 ]. The appearance of a new nodule within the mass, showing nodular or ring enhancement, indicates disease progression.
Peritoneal and omental spread
In this study we observed peritoneal deposits in 12 cases. All showed solid heterogeneous enhancement. There was no evidence of hemorrhage into the deposits in any case. In four cases the nodules were multiple and diffusely involved (omental caking). In two cases, due to extensive deposits, the origin could not be made out [ Figure 4 ]. Ascites was observed in only one case. b a is rare, as the tumor deposits do not cause inflammation. Ascites is more likely attributable to the treatment rather than the tumor itself.
Lymph node metastasis
In two of our cases (one a case of rectal GIST and the other a small bowel GIST ) there were lymph node metastases in the inguinal region; one appeared as a solid heterogeneously enhancing mass similar to the primary tumor [ Figure 7 ] and the other was hypodense with peripheral enhancement.
The prevalence of lymph node (LN) metastasis is reported to occur in 1.1 to 3.4% of the cases. [10] After the tumor cells invade the liver they have a higher probability to spread to the peripheral blood and migrate to the peripheral lymph nodes. Zhang Q reported a case of gastric GIST, with metastasis in the inguinal lymph nodes. [11] In children and young adults, especially when Carney's triad is present, the LN metastasis is common compared to sporadic GIST (29% vs. 2%). The cause of this behavior is not fully understood. When a tumor extends beyond the serosal tumor seedling, a peritoneal implant occurs. Most of the peritoneal spread is by the tumor seedling during surgery / biopsy. Peritoneal deposits are often large discrete masses that look like the primary tumor and can extend up to the pelvis [Figures 1  and 4 ]. The attenuation and enhancement pattern is similar to that of the primary lesion. A hyperattenuating enhancing mass, with areas of necrosis, hemorrhage, and cystic degeneration are seen. Tumor vessels may be seen. They may appear as large discrete masses / multiple nodules, involving the peritoneal surface and sub-peritoneal spaces, and less commonly it may be a diffuse hypervascular omental / peritoneal caking [ Figure 5 ]. [8] With treatment the tumor deposits may liquefy. Sometimes the origin of GIST cannot be established because of extensive peritoneal metastasis. Due to hypervascularity there can be GI bleeding or hemoperitoneum [ Figure 6 ], and the size may get reduced. [9] Calcification of myxohyaline and hemorrhagic stroma may occur. Mesenteric masses grow around the vessels and rarely produce thrombosis. Ascites In some studies the expression of the lymphatic endothelial marker D2-40 / podoplanin in carcinoma cells and the presence of intra-tumoral lymphatics have been correlated with tumor invasiveness and LN metastasis. [12] Metastatic LN may appear as a primary mass with similar characteristics of attenuation and enhancement, and sometimes it may be hypoechoic [ Figure 7 ]. When LN metastasis is predominant, other conditions like adenocarcinoma and lymphoma of the bowel should be thought of as differential diagnosis.
Lung and bone metastasis
We had only one case of metastasis to the sacroiliac bone and in three cases the deposits were seen in the lung. The bone deposit was a lytic lesion with large enhancing soft tissue [ Figure 8 ]. In patients with lung metastasis, multiple nodules along with deposits in the liver / peritoneum were noted [Figures 8 and 9 ].
Metastasis to the lung and bones is rare and occurs late in the course of the disease. [13] Isolated bone metastasis is rare and most of the time bone metastasis is associated with liver and peritoneal spread. Incidence of bone metastasis is about 5%. [14] Bone metastasis is seen mostly in the spine and pelvis [ Figure 8 ]. Skull metastasis was reported in a case of rectal GIST in a recent report. [15] It was a lytic lesion like in our case. A Jain and colleagues reported a case of mesenteric GIST in a 55-year-old male, who had undergone jejunostomy three years earlier and presented with a palpable lesion in the scalp. [13] He had huge hepatomegaly as well. Investigations proved bone and hepatic metastases. Lung metastasis accounts for 7.1% of all lesions. Lung lesions are rare; but have been increasingly reported in recent years due to longer survival of patients following treatment [Figures 8 and 9 ]. Multiple pulmonary metastases from the jejunum, in a 75-year-old male patient, was reported by Gurer et al., in a recent study. [16] 
Cutaneous deposits
Subcutaneous deposits were seen in two of our cases; one was a jejunal GIST and the other primary site could not be observed due to extensive peritoneal deposits. They were solid masses with heterogeneous enhancement [ Figure 10 ].
Cutaneous deposits occur in about 1% of the advanced GISTs and are mostly associated with an abdominal laparotomy scar. The deposit characteristics are similar to the primary mass [ Figures 1 and 10 ]. Kroep et al., recently reported a 69-year old female patient with GIST, who was resistant to Imatinib and presented with a subcutaneous nodule in the right arm. Histopathology confirmed the metastasis in her case. [17] CONCLUSION A CT scan is the modality of choice for diagnosis, staging, and follow-up. The characteristics of the primary mass as well as the spread to other sites and the response to chemotherapy are well studied by imaging modalities. The mesentery, omentum, and liver are the most frequent sites for metastasis. Other sites that have been rarely reported to be involved in the past are increasingly recognized to show metastasis, due to longer survival of the patients in the current era of better chemotherapy. 
